Pacira Pharmaceuticals Inc (NASDAQ:PCRX)

78.21
Delayed Data
As of May 29
 -1.87 / -2.34%
Today’s Change
65.00
Today|||52-Week Range
121.95
-11.79%
Year-to-Date

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Pacira Pharmaceuticals Inc have a median target of 98.00, with a high estimate of 127.00 and a low estimate of 70.00. The median estimate represents a +25.30% increase from the last price of 78.21.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Buy stock in Pacira Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.09
Sales
$66.4M
Reporting Date
Jul 30

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 183.33%
 
 
 
 
 
 
Growthannually 208.06%
 
 
 
 
 
 

Sales

Growthquarterly 13.93%
 
 
 
 
 
 
Growthannually 40.46%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account